(Q37771646)

22 August 2017

1 reference

title

The need for routine physical health care in schizophrenia (English)

1 reference

22 August 2017

0 references

A-L Montejo

1

1 reference

PubMed ID

20620884

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

25 Suppl 2

1 reference

22 August 2017

S3-5

1 reference

Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Prolactin awareness: an essential consideration for physical health in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Clinicians' recognition of the metabolic adverse effects of antipsychotic medications.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Do guidelines for severe mental illness promote physical health and well-being?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Sexual function in chronic illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Physical illness and schizophrenia: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Obesity as a risk factor for antipsychotic noncompliance.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

The impact of weight gain associated with atypical antipsychotic use in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2810%2971699-0

7 January 2021

10.1016/S0924-9338(10)71699-0

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20620884